Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism.
To construct a versatile model host for heterologous expression of genes encoding secondary metabolite biosynthesis, the genome of the industrial microorganism Streptomyces avermitilis was systematically deleted to remove nonessential genes. A region of more than 1.4 Mb was deleted stepwise from the 9.02-Mb S. avermitilis linear chromosome to generate a series of defined deletion mutants, corresponding to 83.12-81.46% of the wild-type chromosome, that did not produce any of the major endogenous secondary metabolites found in the parent strain. The suitability of the mutants as hosts for efficient production of foreign metabolites was shown by heterologous expression of three different exogenous biosynthetic gene clusters encoding the biosynthesis of streptomycin (from S. griseus Institute for Fermentation, Osaka [IFO] 13350), cephamycin C (from S. clavuligerus American type culture collection (ATCC) 27064), and pladienolide (from S. platensis Mer-11107). Both streptomycin and cephamycin C were efficiently produced by individual transformants at levels higher than those of the native-producing species. Although pladienolide was not produced by a deletion mutant transformed with the corresponding intact biosynthetic gene cluster, production of the macrolide was enabled by introduction of an extra copy of the regulatory gene pldR expressed under control of an alternative promoter. Another mutant optimized for terpenoid production efficiently produced the plant terpenoid intermediate, amorpha-4,11-diene, by introduction of a synthetic gene optimized for Streptomyces codon usage. These findings highlight the strength and flexibility of engineered S. avermitilis as a model host for heterologous gene expression, resulting in the production of exogenous natural and unnatural metabolites.
Laboratory of Microbial Engineering, Kitasato Institute for Life Sciences, Kitasato University, 1-15-1 Kitasato Sagamihara, Kanagawa 228-8555, Japan.
Mamoru
M
Komatsu
Takuma
T
Uchiyama
Satoshi
S
Omura
David E
DE
Cane
Haruo
H
Ikeda
D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D002513:Cephamycins / Q000096:biosynthesis; D004852:Epoxy Compounds / Q000378:metabolism; D008401:Gas Chromatography-Mass Spectrometry; D017353:Gene Deletion; D015964:Gene Expression Regulation, Bacterial; D020043:Genes, Essential / Q000235:genetics; D005818:Genetic Engineering / Q000379:methods; D016680:Genome, Bacterial / Q000235:genetics*; D007218:Industrial Microbiology / Q000379:methods; D018942:Macrolides / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D005810:Multigene Family / Q000235:genetics*; D009154:Mutation; D000081223:Polycyclic Sesquiterpenes; D012717:Sesquiterpenes / Q000378:metabolism; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism; D013307:Streptomycin / Q000096:biosynthesis; D014169:Transformation, Bacterial
D001426:Bacterial Proteins; D002513:Cephamycins; D004852:Epoxy Compounds; D018942:Macrolides; D000081223:Polycyclic Sesquiterpenes; D012717:Sesquiterpenes; C515348:amorpha-4,11-diene; C522342:pladienolide B; C522343:pladienolide D; C024925:cephamycin C; D013307:Streptomycin